Search results for: hip OA

Reading Rheum

Daniel Hal Solomon, MD, MPH; Joan M. Von Feldt, MD; | November 1, 2007

Handpicked Reviews of Contemporary Literature

Glimpse the Future

Gretchen Henkel | November 1, 2007

Incoming ACR and ARHP presidents tell you what to expect in 2008

2007: A Remarkable Year for ARHP

Karen L. Kerr, MSN, NP, CPNP, APRN-BC | November 1, 2007

As I write this column, we are preparing to meet in Boston for the 2007 ACR/ARHP Annual Scientific Meeting, and my year as the ARHP president is coming to end. It has been a remarkable year for the ARHP, as we have made significant progress toward achieving the goals identified in our Long-Range Plan…

Become a Champion for RA

Staff | November 1, 2007

Ask any rheumatologist about the state of RA as a disease and you’re likely to get the same answer: There’s reason for great optimism and there’s a lot of work to be done.

Reckoning of a Presidential Year

Neal S. Birnbaum, MD | November 1, 2007

The past year was filled with accomplishments and I take away wonderful memories

A Golden Anniversary

Jane Jerrard | November 1, 2007

Arthritis & Rheumatism Celebrates Its 50th Year

What Gets a Good Rheumatologist Sued?

Dennis J. Boyle, MD | November 1, 2007

Pitfalls to avoid and habits that protect you from malpractice suits

Pursue Remission

Carol A. Wallace, MD | November 1, 2007

Disease remission should be the goal for all rheumatologists treating childhood arthritis

Urge Congress to Support the Arthritis Act

Staff | October 1, 2007

The ACR strongly urges Congress to enact the “Arthritis Prevention, Control, and Cure Act of 2007” (S. 626/H.R.1283), introduced by Senators Edward Kennedy (D-Mass.) and Christopher Bond (R-Mo.) and Representatives Anna Eshoo (D-Calif.) and Chip Pickering (R-Miss.).

Enhanced Opportunities at the 2007 Meeting

Staff | October 1, 2007

The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.